Skip to main content
. 2016 Oct 27;5(6):761–765. doi: 10.3892/br.2016.793

Figure 1.

Figure 1.

Changes in serum levels of complement and hs-CRP in AMI patients. (A) Quantitative analysis data reveal that serum hs-CRP levels of patients with AMI at day 3 was significantly higher than those on days 1 and 7 and in the control group. (B) Quantification of serum C3 levels. Patients with AMI on day 3 demonstrated significantly higher serum C3 levels on days 1 and 7, and compared with the control group. (C) Serum C4 levels of patients with AMI were measured at different time-points. (D) ELISA detection of C5b9 levels of patients with AMI in the serum samples on days 1, 3 and 7. Data are expressed as the mean ± standard deviation. *P<0.05 vs. control, #P<0.05 vs. day 1 and day 7. hs-CRP, high-sensitivity C-reactive protein; AMI, acute myocardial infarction.